Research Article

Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma

Table 3

Dosimetric comparisons of OARs between RapidArc and HT plans.

OARDose ParameterRapidArcHTP-value
Average (SD)Average (SD)

Spinal CordDmax (cGy)3603(368)3412(149)NS
D1cc (cGy)3331(400)3240(131)NS
D0.1cc (cGy)3429(408)3347(132)NS
Brain StemDmax (cGy)4965(130)4912(103)NS
D1cc (cGy)4524(146)4304(179)0.012
D0.1cc (cGy)4767(149)4684(151)NS
Optic ChiasmDmax (cGy)3282(1436)4829(735)<0.001
D2 (cGy)3003(1220)4763(736)<0.001
Optic Nerve IDmax (cGy)2745(1728)4906(1025)<0.001
D2 (cGy)2352(1578)4822(989)<0.001
Optic Nerve CDmax (cGy)3040(1595)4921(763)<0.001
D2 (cGy)2621(1419)4807(731)<0.001
Temporal Lobe IDmax (cGy)6643(350)6447(285)0.015
V60Gy (%)1.7(1.3)2.1(1.6)NS
Temporal Lobe CDmax (cGy)6512(101)6283(162)0.001
V60Gy (%)1(0.5)1.1(0.6)NS
Lens IDmax (cGy)524(98)427(119)0.009
D2 (cGy)505(93)400(94)0.002
Dmean (cGy)431(97)299(46)<0.001
Lens CDmax (cGy)509(87)425(135)0.047
D2 (cGy)492(86)391(100)0.005
Dmean (cGy)418(92)291(47)<0.001
Parotid IDmean (cGy)4114(493)3636(514)0.002
Dmedian (cGy)3791(618)3437(809)NS
V30Gy (%)70.4(13.9)54.8(9.8)0.009
Parotid CDmean (cGy)3909(431)3336(449)<0.001
Dmedian (cGy)3585(525)3033(658)0.018
V30Gy (%)67.3(12.7)48.2(9.6)0.005
PituitaryDmax (cGy)5548(1023)5786(521)NS
BodyV15 Gy (%)32.1(5.2)40(15.1)NS
V20 Gy (%)27.9(4.9)34.5(13.7)NS
V30 Gy (%)19.9(4.3)23.1(11)NS
V40 Gy (%)12.5(2.9)14.2(6.7)NS

OAR: organ at risk; SD: standard deviation; Dmax: maximum point dose; D1cc: maximum dose encompassing 1cc of the structure; D0.1cc: maximum dose encompassing 0.1cc of the structure; D2: maximum dose encompassing 2% of the structure; Dmean: mean dose of the structure; Dmedian: median dose of the structure; V15,20,30,40,60 Gy: the relative volume of the structure receiving over 15,20,30,40,60Gy.